In vitro effect of hydro alcoholic extract of Adiantum capillus‑veneris Linn. on calcium oxalate crystallization

Ajij Ahmed, Nasreen Jahan, Abdul Wadud, Alia Bilal, Syeda Hajera

Abstract


Background: Adiantum capillus‑veneris Linn. is widely used in the management of urolithiasis in Unani system of medicine.
Aim: To evaluate the effect of the hydro alcoholic extract of A. capillus‑veneris Linn. on calcium oxalate crystallisation by in vitro
study. Materials and Methods: The study includes crystallization, nucleation and aggregation assay. Crystallization was induced by
addition of 50 µl of 0.1 M sodium oxalate in whole urine in the absence and the presence of extract at different concentrations (0.50 mg, 0.75 mg and 1 mg). The nucleation and aggregation rates were followed at 620 nm after mixing calcium chloride and sodium oxalate solution and in a buffered solution containing calcium oxalate monohydrate crystals, respectively. The rate was evaluated by comparing the slope of turbidity in the presence of extract with that of control using the spectrophotometer. Crystals in the urine were also analysed by light microscopy. Results and Conclusion: Extract of the test drug inhibited the crystallization in solution; less and smaller particles were observed in the presence of extract. These results were further confirmed in the nucleation assay, though the rate of nucleation was not inhibited but number of crystals was found to be decreased. The test drug also inhibited crystal aggregation. It can be concluded therefore, that the test drug possesses significant antilithiasic activity.
Key words: Calcium oxalate crystallization, in vitro, lithotriptic activity, unani medicine, urolithiasis

Full Text:

PDF

References


Satish R, Natarajan K, Nikhad MM. Effect of Hygrophila spinosa

T. anders on ethylene glycol induced urolithiasis in Rats. Asian J

Pharm Clin Res 2010;3:61‑3.

Abdel‑Aal EA, Daosukho S, El‑Shall H. Effect of supersaturation

ratio and Khella extract on nucleation and morphology of kidney

stones. J Cryst Growth 2009;311:2673‑81.

Deorao MA, Vaishali M, Santi PB, Shardha PC. Antilithiatic effect of

Achyranthus aspera Linn. leaves extract on ethylene glycol induced

nephrolithiasis. J Pharm Res 2009;5:994‑7.

Pandeya A, Prajapati R, Panta P, Regmi A. Assessment of kidney

stone and prevalence of its chemical compositions. Nepal Med

Coll J 2010;12:190‑2.

Butterweck V, Khan SR. Herbal medicines in the management

of urolithiasis: Alternative or complementary? Planta Med

;75:1095‑103.

Ghani N. Khazainul Advia. 1st ed. New Delhi: Idara Kitabus Shifa;

p. 1360‑1.

Sina I. Al Qanoon Fil Tibb (Urdu Translation by Kantoori GH).

New Delhi: Idara Kitabus Shifa; 2010. p. 298.

Hakeem MA. Mufradate Azizi. 1st ed. New Delhi: CCRUM,

Ministry of Health Family Welfare; 2009. p. 80.

Anonymous. Standardisation of Single Drugs of Unani Medicine,

Part II. New Delhi: CCRUM; 1992. p. 240‑7.

Nabi MG. Makhzane Mufradat Wa Murakkabat. 2nd ed. New Delhi:

CCRUM, Ministry of Health Family Welfare; 2007. p. 249.

Guha P, Mukhopadhyay R, Gupta K. Antifungal activity of

the extracts and extracted phenols from gametophytes and

sporophytes of two species of Adiuntum. Taiwania 2005;50:272‑83.

Parihar P, Parihar L, Achaleshwar B. In vitro antibacterial activity

of fronds (leaves) of some important pteridophytes. J Microbiol

Antimicrob 2010;2:19‑22.

Mehmood A, Khan MA, Ahmad M, Zafar M, Khan H,

Muhammad N, et al. Medicinal plants used for the treatment of

jaundice and hepatitis based on socio‑economic documentation.

Afr J Biotechnol 2009;8:1643‑50.

Pourmorad F, Hosseinimehr SJ, Shahabimajd N. Antioxidant

activity, phenol and flavonoid contents of some selected Iranian

medicinal plants. Afr J Biotechnol 2006;5:1142‑5.

Atmani F, Slimani Y, Mbark AN, Bnoham M, Ramdani A. In vitro

and in vivo antilithiasic effect of saponin rich fraction isolated from

Hernia hirsuta. J Bras Nefrol 2006;4199‑03.

Khan SR, Glenton PA, Backov R, Talham DR. Presence of lipids in

urine, crystals and stones: Implications for the formation of kidney

stones. Kidney Int 2002;62:2062‑72.

Patel PK, Nayak N, Patel H, Patel MA, Saralai MG, Gandhi TR.

Inhibition of calcium oxalate crystallization by the fruit extract

of Solanum xanthocarpum Schrad and Wendl and Pedalium murex

Linn. Int J Pharm Res 2010;4:46‑52.

Atmani F, Khan SR. Effects of an extract from Herniaria hirsuta on

calcium oxalate crystallization in vitro. BJU Int 2000;85:621‑5.

Khan SR. Structure and development of calcific urinary stones. In:

Bonucci E, editor. Calcification in Biological Systems. Boca Raton:

CRC Press; 1992. p. 345‑63.

Robertson WG, Peacock M, Marshall RW, Marshall DH, Nordin BE.

Saturation‑inhibition index as a measure of the risk of calcium

oxalate stone formation in the urinary tract. N Engl J Med

;294:249‑52.

Kok DJ, Khan SR. Calcium oxalate nephrolithiasis, a free or fixed

particle disease. Kidney Int 1994;46:847‑54.

Dyer R, Nordin BE. Urinary crystals and their relation to stone

formation. Nature 1967;215:751‑2.

Wesson JA, Ward MD. Role of crystal surface adhesion in kidney

stone disease. Curr Opin Nephrol Hypertens 2006;15:386‑93.




DOI: http://dx.doi.org/10.22377/ijgp.v7i2.305

Refbacks

  • There are currently no refbacks.